Overview
Core Company Belief:
Anthracyclines are among the most important treatments for acute myeloid leukemia (AML) and advanced soft tissue sarcoma (STS).
Annamycin allows, for the first time ever, a clear majority of patients to benefit from these treatments.
Priority Development Pipeline
Your tooltip content goes here
Your tooltip content goes here
Your tooltip content goes here
Your tooltip content goes here
Priority Development Pipeline
Your tooltip content goes here
Your tooltip content goes here
Your tooltip content goes here
Your tooltip content goes here